Blood and Cancer Institute’s Post

Delve into the intricate journey of cancer within the body: from a single cell mutation to its relentless spread. 🌟 Understand its origins, progression, and the hope offered by advanced treatments at the Blood and Cancer Institute. 🧬💉 FOR MORE DETAILS OR APPOINTMENT 🌟  📲+917575022822/11  ☎️0261-3551153 [Cancer Awareness, Cancer Diagnosis, Cancer Treatment, Blood and Cancer Institute, Surat Healthcare] #CancerAwareness #MedicalScience #Healthcare #Hope #CancerTreatment #Diagnosis #AdvancedTherapies #HealthcareInstitute #MedicalInnovation #HopeForPatients #FightAgainstCancer #EarlyDetection #Research #SuratHealthcare #BloodandCancerInstitute

Men, if you’re 50 or older and average risk for prostate cancer, you should get screened every one to two years. Men who are at high risk include: African-American men, those with a family member diagnosed with prostate cancer under the age of 60 or those with a known genetic mutation that confer risk of cancer (BRCA 1/2, Lynch syndrome). For those at high risk, you should start screening between 40 to 45 years of age. Men of average risk should start screening at 50. You can get screened at your primary care office. What is prostate cancer screening? More from Dr. Ajaz Bulbul, medical oncologist with St. Joseph’s/Candler Infusion Center in Hinesville, a partnership with the Lewis Cancer & Research Pavilion and Liberty Regional Medical Center: https://lnkd.in/etp_AKwR #prostatecancer #cancer #menshealth #africanamericanhealth #africanamericanhealthcare #cancertreatment #healthcare #oncologist #oncology #medicaloncologist

Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death overall and in men worldwide, with almost 2.5 million cases (1 in 8 cancers) and 1.8 million deaths (1 in 5 deaths). Early detection saves lives. If anyone experiences persistent respiratory issues, do not delay in seeking a doctor. Join us in doing our part to help put an end to lung cancer, through providing access to high end generic anticancer medicine to you. #lung_cancer #cancer_awareness #oncology #cancer_support #NSCLC #Osimert #TAGRISSO #Adakras #KRAZATI

🔬 Penile Rehabilitation Effectiveness After Prostate Cancer Treatment: A Systematic Review of Randomized Controlled Trials 🔬 I’m excited to announce the publication of my systematic review focusing on penile rehabilitation following prostate cancer treatment. This review critically evaluates randomized controlled trials to assess the effectiveness of various rehabilitation strategies. 📈 Key Findings: Comprehensive analysis of rehabilitation methods and their impact on erectile function Evaluation of different therapeutic approaches and their success rates Insights into best practices and future research directions Dive into the full review to understand how penile rehabilitation can improve outcomes after prostate cancer treatment. https://lnkd.in/drAik5AS #ProstateCancer #PenileRehabilitation #MedicalResearch #ErectileFunction #HealthOutcomes

A meta-analysis of pooled cohort studies (DOI: 10.1007/s00432-024-05672-y) involving 4224 gastric cancer cases identifies tertiary lymphoid structures (TLS) as significant for prognosis and response to immunotherapy. Patients with higher TLS levels had a marked association with smaller tumor sizes, less advanced disease stages, and better overall survival rates, highlighting TLS as a biomarker for enhanced immunoreactivity and patient outcomes. #Oncology #ClinicalOncology #Biomarkers #PatientCare

In our recent editorial, we delved into the evolving landscape of first-line treatment for metastatic gastric cancer, highlighting the cautious optimism that current research affords. Key trials like CHECKMATE-649 and the developments in biomarker identification, such as PD-L1 and CLDN18.2, suggest a nuanced yet hopeful path forward in treating this challenging disease. While the integration of immunotherapy and targeted therapies into treatment protocols marks a significant step, the journey towards truly personalized medicine is ongoing. The complexities of tumor biology and patient response underline the importance of continued research and collaboration in this field. Alex Friedlaender Hiba Mechahougui Thibaud Koessler https://lnkd.in/e4_iCmq9 #Oncology #GastricCancer #ClinicalResearch #PersonalizedMedicine #MedicalEditorial

𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰⁉️ In #Bangladesh, #BRCA1 and #BRCA2 mutations play a significant role in #hereditary #breast and #ovarian cancer, as seen in other South Asian countries. 👉While specific #national #statistics are still emerging, research indicates that about 𝟓-𝟔% of 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐢𝐧 𝐬𝐢𝐦𝐢𝐥𝐚𝐫 𝐩𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐀𝐬𝐢𝐚 𝐜𝐚𝐫𝐫𝐲 𝐦𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞𝐬𝐞 𝐠𝐞𝐧𝐞𝐬. 💡These #mutations notably increase #cancer risk, underscoring the importance of #genetic testing for early #detection and #personalized treatment strategies. As #awareness grows and more #genetic data is gathered, we expect more accurate and population-specific statistics to emerge, helping to improve precision oncology for patients across #Bangladesh 🇧🇩. #BRCA #GeneticTesting #CancerResearch #BreastCancerAwareness #PrecisionOncology #Bangladesh #4baseCare #DidYouKnow

🔍 Stage IIB/C vs. Stage IIIA Colon Cancer Survival Paradox: Recent study explores the surprising survival outcomes between these stages. 📊🧬 Findings: - 5-year survival rates: 84.3% for optimally treated Stage IIIA vs. 72.8% for Stage IIB/C. - Stage T1N1 shows the highest survival among Stage IIIA, significantly better than Stage T4bN0 from Stage IIC. - Stage IIC associated with a 17% higher risk of mortality compared to IIIA, showcasing a 21% reduction in death risk. 🤔 Conclusion: The survival paradox persists even with adequate treatment and lymph node retrieval. More research needed to understand and integrate these insights into future cancer staging. #ColonCancer #CancerResearch #Oncology

Union for International Cancer Control (UICC) - How a handheld device is enabling quick breast cancer screenings in India https://lnkd.in/d7iFYZpC #Cancer #CancerScreening #BreastCancer #CancerAwareness #CancerScreening #EarlyDetection #Medicine #India #Health #Oncology #OncoDaily

Colorectal Cancer Worldwide: World Health Organization Perspective At OncoDaily’s Global Cancer Movement (Dec 6-8, 2024), Andre Ilbawi, Technical Lead for Cancer Control at the World Health Organization, addressed disparities in colorectal cancer care. The session focused on strategies to improve prevention, detection, and treatment for one of the most underperforming cancers worldwide. https://lnkd.in/dKC-tyfy #Cancer #ColorectalCancer #CancerCare #GlobalCancerMovement #Medicine #Health #WHO #Oncology #OncoDaily